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INTRODUCTION: Aristaless-related homeobox (ARX) gene is implicated in non-syndromic and 
syndromic intellectual disability (ID), namely X-Linked Lissencephaly with Ambiguous Genitalia, 
Agenesis of Corpus Callosum with Abnormal Genitalia and Early Infantile Epileptic 
Encephalopathy, among other phenotypes. Pathogenic mutations leading to polyalanine tract 
expansions in the ARX protein were reported in the majority of patients. Since ARX is one of 
the most frequently mutated genes causing ID with an hotspot region in exon2 and has a 
pleiotropic effect, it has been considered a good candidate for routine molecular screening in 
patients with ID, similarly to what is now recommended for Fragile X Syndrome. 
OBJECTIVES: Molecular analysis of the most frequent mutations in the ARX gene. 
MATERIAL AND METHODS: Multiplex assay for FMR1, AFF2 and ARX genes and ARX 
sequencing (poster submitted). 
RESULTS: Family 1: An eight years old boy was referred for non-syndromic ID. The pathogenic 
mutation c.429_452dup (ARXdup24) was detected in hemizygosity, causing an expansion from 
12 to 20 alanines in the second polyalanine track of the ARX protein. Family 2: Two brothers 
with four and nine years old were referred for ID and macrocephaly. The disease causing 
mutation c.429_452dup (ARXdup24) was also identified in both brothers. Family 3: A twenty 
month old boy was referred for severe psychomotor delay, microcephaly, lissencephaly and 
epilepsy. The variant c.322_333dup (ARXdup12) was identified, resulting in an expansion from 
16 to 20 alanines in the first polyalanine group of the ARX protein. 
DISCUSSION: The screening of mutations in the ARX gene, followed by sequencing, enabled 
the diagnosis of ARX-Related Disorders in three families, presenting with different clinical 
phenotypes. The simultaneous screening of hotspot mutations in the ARX exon 2 gene, as well 
as in the FMR1 and AFF2 genes that cause intellectual disability, was implemented in the Unit 
of Molecular Genetics (Centro de Genética Médica Dr. Jacinto de Magalhães/CHP) (poster 
submitted). Whenever a variant is detected in this screening, sequencing is performed to 
precisely characterize the deletions/duplications identified. Furthermore complete sequencing 
of the ARX gene should be requested, when ARX-Related Disorders are suspected besides an 
exon 2 negative screening. The diagnosis of ARX-Related Disorders is crucial for genetic 
counselling of at risk family members. 
CONCLUSIONS: Molecular analysis of the ARX gene should be performed in patients with non-
syndromic and syndromic ID and in females with family history of ID, particularly those 
suggestive of X-linked inheritance pattern. 
